Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Pierre Preziosi

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
The Lancet. Infectious Diseases|August 19, 2018
NmCV-5 meningococcal vaccine: Neisseria meningitidis' nemesis?Marie-Pierre Preziosi, Brian Greenwood
Transactions of the Royal Society of Tropical Medicine and Hygiene|September 3, 2021
Defeating meningitis by 2030 - an ambitious targetBrian Greenwood, Samba Sow, Marie-Pierre Preziosi
Human Vaccines & Immunotherapeutics|April 13, 2012
Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM)Carl E Frasch, Marie-Pierre Preziosi, F Marc LaForce
Human Vaccines & Immunotherapeutics|October 3, 2017
Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next stepsF Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Viral Immunology|November 9, 2017
Lessons from the Meningitis Vaccine ProjectF Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVacYuxiao Tang, Brian D Plikaytis, Marie-Pierre Preziosi, et al.
Tropical Medicine & International Health : TM & IH|November 9, 2010
The epidemiology of meningococcal disease in IndiaDavid Sinclair, Marie-Pierre Preziosi, T Jacob John, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Costs of Neisseria meningitidis Group A Disease and Economic Impact of Vaccination in Burkina FasoAnaïs Colombini, Caroline Trotter, Yvette Madrid, et al.
Bulletin of the World Health Organization|March 6, 2020
Data sharing for novel coronavirus (COVID-19)Vasee Moorthy, Ana Maria Henao Restrepo, Marie-Pierre Preziosi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis BeltAndromachi Karachaliou, Andrew J K Conlan, Marie-Pierre Preziosi, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The Lancet. Infectious Diseases|August 19, 2018
NmCV-5 meningococcal vaccine: Neisseria meningitidis' nemesis?Marie-Pierre Preziosi, Brian Greenwood
Transactions of the Royal Society of Tropical Medicine and Hygiene|September 3, 2021
Defeating meningitis by 2030 - an ambitious targetBrian Greenwood, Samba Sow, Marie-Pierre Preziosi
Human Vaccines & Immunotherapeutics|April 13, 2012
Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM)Carl E Frasch, Marie-Pierre Preziosi, F Marc LaForce
Human Vaccines & Immunotherapeutics|October 3, 2017
Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next stepsF Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Viral Immunology|November 9, 2017
Lessons from the Meningitis Vaccine ProjectF Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVacYuxiao Tang, Brian D Plikaytis, Marie-Pierre Preziosi, et al.
Tropical Medicine & International Health : TM & IH|November 9, 2010
The epidemiology of meningococcal disease in IndiaDavid Sinclair, Marie-Pierre Preziosi, T Jacob John, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Costs of Neisseria meningitidis Group A Disease and Economic Impact of Vaccination in Burkina FasoAnaïs Colombini, Caroline Trotter, Yvette Madrid, et al.
Bulletin of the World Health Organization|March 6, 2020
Data sharing for novel coronavirus (COVID-19)Vasee Moorthy, Ana Maria Henao Restrepo, Marie-Pierre Preziosi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis BeltAndromachi Karachaliou, Andrew J K Conlan, Marie-Pierre Preziosi, et al.
Pageof 5